Switch
Switch, licence 80056853: active licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- Max International LLC
- NPN or DIN-HM
- 80056853
- Status
- Active licence
- Licence date
- 30 December 2014
- Revision date
- 12 April 2019
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine D: up to 25.02 µg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 5 µg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 15 mg a day according to the dosing instructions published by Health Canada (6 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- À vérifier
Vitamine B6: up to 15 mg a day according to the dosing instructions published by Health Canada, above the limite de sécurité from EFSAEuropean Food Safety Authority. for adults (12 mg a day). Le repère de l'EFSA porte sur l'apport total d'une journée, alimentation et compléments.
limite supérieure de sécurité (UL). EFSA, Overview on Tolerable Upper Intake Levels (version 11, August 2025), retrieved 21 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Acide d-pantothénique | 2.0 mg | Not calculated |
| Acide DL-alpha-lipoïque | 300.0 mg | Not calculated |
| Vitamine B12 | 12.5 mcg | 75 µg |
| Vitamine D Potency : 166.67 UI | 4.17 mcg | 25.02 µg |
| Thiamine | 0.5 mg | 3,000 µg |
| Vitamine B6 | 2.5 mg | 15,000 µg |
| Potassium | 3.6 mg | 21,600 µg |
| Panax quinquefolius Source : Racine Extraction ratio : 2:1 Dry plant equivalent : 17 mg Potency : 5.0 % Ginsenosides | 8.5 mg | Not calculated |
| (S)-N5-Carbamoylornithine | 8.5 mg | Not calculated |
| L-Leucine | 8.5 mg | Not calculated |
| D-Ribose-L-cystéine Potency : 1.44 mg L-Cysteine | 3.0 mg | Not calculated |
| D-Ribose-L-cystéine Potency : 44.7 % L-Cysteine | Not specified | Not calculated |
| D-Ribose-L-cystéine Potency : 55.3 % Ribose | Not specified | Not calculated |
| D-Ribose-L-cystéine Potency : 1.78 mg Ribose | Not specified | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Éthyl cellulose, Maltodextrine, Gélatine, Cellulose microcristalline, Stéarate de magnésium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 2.0 Capsule | 3.0 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
To be used with a program of reduced intake of dietary calories and increased physical activity (if possible) to help in weight management. Assists in weight management when used with a program of reduced intake of dietary calories and increased physical activity (if possible). Provides antioxidants for the maintenance of good health. Helps the body to metabolize carbohydrates, proteins and fats. Helps to promote healthy glucose metabolism. Helps to prevent vitamin D, thiamine, vitamin B6, vitamin B12, and pantothenic acid deficiency.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
For adults only. Do not exceed dose. Consult a health care practitioner prior to use if you are pregnant or breastfeeding, if you have diabetes, or if you are taking blood thinners or digoxin. Discontinue use if you experience allergic skin reaction such as itching sensation or urticaria. If you are experience symptoms of hypoglycaemia including feeling of anxiety, dizziness, tremor, sweating, nausea or headache, discontinue use and consult a health care practitioner.
Source
Official Health Canada record, licence 80056853
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
List recorded in 2019. Photograph the packaging to check whether it has changed.
Has the product changed? Photograph the packaging.